This educational activity is intended for rheumatologists and other members of the health care team who care for patients with SARD-ILD. Explore the latest in SARD-ILD care through an interactive ...
The goal of this activity is to educate clinicians on the symptoms and presentation of pulmonary hypertension-interstitial lung disease (PH-ILD) to administer the appropriate diagnostic tests, ...
RA-ILD significantly increases mortality, with a median survival of less than 3 years post-diagnosis. Key risk factors include male gender, older age, smoking, pulmonary comorbidities, rheumatoid ...
Patients with rheumatoid arthritis (RA) face increased risk for interstitial lung disease (ILD) and comorbidities appear to raise it further. This retrospective study sought to compare different ...
The prevalence of interstitial lung disease (ILD) across connective tissue disorders (CTDs) and its persistent standing as a leading cause of death in patients with CTDs challenge rheumatologists to ...
IPF is a chronic, progressive lung disease marked by lung tissue thickening and scarring, leading to reduced lung function. It is a specific type of interstitial lung disease, which includes various ...
In the article that accompanies this editorial, Rugo et al 5 review the real-world practices for the management of T-DXd–related ILD in breast cancer, providing helpful advice on strategies aimed at ...
Emerging Therapeutic Directions for Cancers With Mutations Within the Complex Proteins Associated With Set1 Family: A Systemic Review Interstitial lung disease (ILD) and pneumonitis have both been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results